Company Details
Dicerna Pharmaceuticals
Overview
Biotechnology company developing RNA-based treatments for rare diseases.
Total Raised
$89 M
Rounds
3
Links
Verticals
Biotechnology
Genetics
Health Care
Pharmaceutical
Investment History
Series C
Aug 2013
$60M
Series B
Oct 2010
$4M
Series B
Aug 2010
$25M